These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Treatment of drug resistance in epilepsy: one step at a time. Sisodiya SM; Bates SE Lancet Neurol; 2006 May; 5(5):380-1. PubMed ID: 16632304 [No Abstract] [Full Text] [Related]
12. Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy. Summers MA; Moore JL; McAuley JW Ann Pharmacother; 2004 Oct; 38(10):1631-4. PubMed ID: 15328394 [TBL] [Abstract][Full Text] [Related]
13. [Problem drug resistance]. Oberpichler-Schwenk H Med Monatsschr Pharm; 2011 May; 34(5):151. PubMed ID: 21644372 [No Abstract] [Full Text] [Related]
14. Seizure relapse and development of drug resistance following long-term seizure remission. Schiller Y Arch Neurol; 2009 Oct; 66(10):1233-9. PubMed ID: 19822778 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategies in the choice of antiepileptic drugs. de Borchgrave V; Delvaux V; de Tourchaninoff M; Dubru JM; Ghariani S; Grisar T; Legros B; Ossemann M; Sadzot B; Tugendhaft P; Van Bogaert P; van Rijckevorsel K; Acta Neurol Belg; 2002 Mar; 102(1):6-10. PubMed ID: 12094563 [TBL] [Abstract][Full Text] [Related]
16. Pharmacoresistant epilepsy: from pathogenesis to current and emerging therapies. Pati S; Alexopoulos AV Cleve Clin J Med; 2010 Jul; 77(7):457-67. PubMed ID: 20601619 [TBL] [Abstract][Full Text] [Related]